Prolongation of rat cardiac allograft survival with arachidonic acid metabolism inhibitor.
D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine; D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism*; D001241:Aspirin / Q000031:analogs & derivatives / Q000494:pharmacology; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation; D008239:Lysine / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D008689:Methacrylates / Q000494:pharmacology; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D013929:Thromboxane B2 / Q000652:urine; D013931:Thromboxanes / Q000502:physiology*; D014184:Transplantation, Homologous
D001095:Arachidonic Acids; D008689:Methacrylates; D013931:Thromboxanes; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D008239:Lysine; C034364:ozagrel; D001241:Aspirin; C010395:acetylsalicylic acid lysinate